Llwytho...
The minimum dose of dexmedetomidine required for cessation of postspinal anesthesia shivering: A prospective observational study
BACKGROUND AND AIMS: Shivering is a common postanesthesia adverse event with multiple etiologies. Dexmedetomidine, a centrally acting alpha-2 adrenergic agonist, is known to reduce the shivering threshold. However, the minimum dose at which dexmedetomidine causes cessation of shivering is unknown. T...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Anaesthesiol Clin Pharmacol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Medknow Publications & Media Pvt Ltd
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791263/ https://ncbi.nlm.nih.gov/pubmed/29416242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/joacp.JOACP_115_16 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|